Evolocumab administration prior to Coronary Artery Bypass Grafting in patients with multivessel coronary artery disease (EVOCABG): study protocol for a randomized controlled clinical trial

Evolocumab administration prior to Coronary Artery Bypass Grafting in patients with multivessel coronary artery disease (EVOCABG): study protocol for a randomized controlled clinical trial

Abstract Background Despite advances in surgical and postoperative care, myocardial injury or infarction (MI) is still a common complication in patients undergoing coronary artery bypass surgery (CABG). Several studies that aimed to reduce postoperative myocardial injury, including those investigati...

Full description

Bibliographic Details
Main Authors: Hye Rim Na, O Sung Kwon, Joon Kyu Kang, Yong Han Kim, Ju Yong Lim
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Trials
Subjects:
PCSK9 inhibitor
Evolocumab
Coronary artery bypass grafting
Ischemia-reperfusion injury
Coronary artery disease
Major adverse cardiovascular events
Online Access:https://doi.org/10.1186/s13063-022-06398-3

Internet

https://doi.org/10.1186/s13063-022-06398-3

Similar Items